Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Cyclacel Pharmaceuticals Inc’s current trading price is -87.02% away from its 52-week high, while its distance from the 52-week low is 12.72%. The stock’s price range over this period has fluctuated between $1.52 and $13.20. The company, operating within the financial sector, had a trading volume of approximately 2.9 million for the day, which was noticeably higher than the average daily share volume of 53490.0 over the last 3 months.
Cyclacel Pharmaceuticals Inc ‘s stock market performance has been somewhat erratic. The company’s stock reached a 1-year high price of $13.20 on 07/19/23, while the lowest value for the same period was recorded at $1.52 on 04/16/24.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Cyclacel Pharmaceuticals Inc (CYCC) has experienced a quarterly decline of -17.62% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.26M.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 2.59, with a change in price of -2.83. Similarly, Cyclacel Pharmaceuticals Inc recorded 152,341 in trading volume during the last 100 days, posting a change of -62.90%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for CYCC stands at 0.07. Similarly, the long-term debt-to-equity ratio is also 0.07.
CYCC Stock Stochastic Average
Today, Cyclacel Pharmaceuticals Inc’s raw stochastic average for the past 50 days stands at 9.58%, indicating a decline from the raw stochastic average of the last 20 days, which was 18.01%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 49.99% and 46.79% respectively.
CYCC Stock Price Performance Analysis
The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. The index has shown a price loss of -35.83% this year. Over the last six months, there has been a stronger performance of -80.77%. The price of CYCC leaped by -10.76% during the last 30 days period. For the last 5-days stocks have slided -7.38%.
